The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
We contrast TRI with price indices, highlighting dividends, corporate actions, and reinvestment assumptions that shape different performance pictures.
24,487 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
A disappointing sale of 7-year notes underscores investor caution as Iran war fears rise. Traders point to a shifting...
As 2025 unfolds, your net worth and daily spending collide to shape your financial future. This guide offers actionab...
A viral post about a person earning $36k a year with $136k in debt and a prize horse has lawmakers and financiers wei...
A rally powered by a small group of tech stocks is raising concerns about the durability of trump’s bull market stand...
A growing body of research ties frequent sauna use to better cardiovascular health and sleep, while households weigh ...
With an average $70,000 salary in the crosshairs, this explainer shows the math and the risks behind replacing work i...
A $1.4 million portfolio that generates roughly $49,000 in annual income could outpace the average California public ...
The NY Fed reports a rise in food insecurity, with more people going hungry now than during the COVID-19 crisis. The ...
A historic SpaceX IPO would signal a new chapter for private space ventures. Mueller, SpaceX’s first employee, now le...
PowerFleet is reshaping fleet management with AI-powered IoT. This guide breaks down what to expect from powerfleet (...
Solana has landed Moody’s on-chain ratings, enabling open access to standardized credit analysis for tokenized assets...